Mutated tumor alleles are expressed according to their DNA frequency

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Castle, John C ^a   Loewer, Martin ^a   Boegel, Sebastian ^a,b   Tadmor, Arbel D ^a   Boisguerin, Valesca ^a,c   De Graaf, Jos ^a   Paret, Claudia ^a   Diken, Mustafa ^a   Kreiter, Sebastian ^a   Türeci, Özlem ^b   Sahin, Ugur ^a,b,c  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c BIONTECH AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANIMAL; COPY NUMBER VARIATION; GENE FREQUENCY; GENETICS; HIGH THROUGHPUT SEQUENCING; MOUSE; MUTATION; NEOPLASM; TUMOR CELL LINE;

ALLELES; ANIMALS; CELL LINE, TUMOR; DNA COPY NUMBER VARIATIONS; GENE FREQUENCY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; MICE; MUTATION; NEOPLASMS;

EID: 84899096455     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04743     Document Type: Article

References (32)

1. Sjoblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274 (2006). (Pubitemid 44571966)
2. Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (2007). (Pubitemid 46398669)
3. Allegra, C. J. et al. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 27, 2091-2096 (2009).
4. Chang, Y. F., Imam, J. S. & Wilkinson, M. F. The nonsense-mediated decay RNA surveillance pathway. Annual review of biochemistry 76, 51-74 (2007).
5. Cartegni, L., Chew, S. L. & Krainer, A. R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3, 285-298 (2002). (Pubitemid 34279797)
6. Shin, N. et al. Identification of frequently mutated genes with relevance to nonsense mediated mRNA decay in the high microsatellite instability cancers. Int J Cancer 128, 2872-2880 (2011).
7. Adey, A. et al. The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line. Nature 500, 207-211 (2013).
8. Zhao, X. et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 64, 3060-3071 (2004). (Pubitemid 38581405)
9. Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22, 568-576 (2012).
10. Gandhi, J. et al. Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS One 4, e4576 (2009).
11. Ha, G. et al. Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer. Genome Res 22, 1995-2007 (2012).
12. Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 30, 413-421 (2012).
13. Soh, J. et al. Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells. PLoS One 4, e7464 (2009).
14. Crisan, A. et al. Mutation discovery in regions of segmental cancer genome amplifications with CoNAn-SNV: a mixture model for next generation sequencing of tumors. PLoS One 7, e41551 (2012).
15. Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994-1007 (2012).
16. Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A 107, 16910-16915 (2010).
17. Pastinen, T. Genome-wide allele-specific analysis: insights into regulatory variation. Nat Rev Genet 11, 533-538 (2010).
18. Babak, T. et al. Global survey of genomic imprinting by transcriptome sequencing. Curr Biol 18, 1735-1741 (2008).
19. Tuch, B. B. et al. Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations. PLoS One 5, e9317 (2010).
20. Li, H. &Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
21. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21 (2013).
22. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
23. Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31, 213-219 (2013).
24. Larson, D. E. et al. Somatic Sniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics 28, 311-317 (2012).
25. Castle, J. C. et al. DNA copy number, including telomeres and mitochondria, assayed using next-generation sequencing. BMC Genomics 11, 244 (2010).
26. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013).
27. Castle, J. C. et al. Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics 15, 190 (2014).
28. Duitama, J., Srivastava, P. & Mandoiu, I. Towards accurate detection and genotyping of expressed variants from whole transcriptome sequencing data. BMC Genomics 13, (2012).
29. Stevenson, K. R., Coolon, J. D. & Wittkopp, P. J. Sources of bias in measures of allele-specific expression derived from RNA-seq data aligned to a single reference genome. BMC Genomics 14, 536 (2013).
30. Li, G. et al. Identification of allele-specific alternative mRNA processing via transcriptome sequencing. Nucleic Acids Res 40, e104 (2012).
31. Glaser, R. L., Ramsay, J. P. & Morison, I. M. The imprinted gene and parent-oforigin effect database now includes parental origin of de novo mutations. Nucleic Acids Res 34, D29-31 (2006).
32. Castle, J. C. et al. Exploiting the mutanome for tumor vaccination. Cancer Res 72, 1081-1091 (2012).